Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
  1. 4 Planned sale Chief Customer Officer sold 3,635 shares at $140.00 ($508,900)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Director sold 15,000 shares at an average $123.25 ($1,848,795)
  4. 4 Shares withheld for taxes Chief Tech Ops Officer gave up 978 shares (to pay taxes)
  5. 4 Shares withheld for taxes Head of R&D, CSO gave up 1,421 shares (to pay taxes)
  6. 4 Open-market sale Director sold 761 shares at $122.93 ($93,550)
  7. 4 Shares withheld for taxes EVP, General Counsel gave up 1,405 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 1,561 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 1,389 shares (to pay taxes)
  10. 4 Open-market sale Director sold 3,135 shares at $122.96 ($385,480)
  11. 4 Shares withheld for taxes EVP, General Counsel gave up 1,734 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Tech Ops Officer gave up 522 shares (to pay taxes)
  13. 4 Shares withheld for taxes Head of R&D, CSO gave up 1,728 shares (to pay taxes)
  14. 4 Grant or award Director acquired 1,846 shares (grant or award)
  15. 4 Grant or award Director acquired 1,846 shares (grant or award)
  16. 4 Grant or award Director acquired 1,846 shares (grant or award)
  17. 4 Grant or award Director acquired 1,846 shares (grant or award)
  18. 4 Grant or award Director acquired 1,846 shares (grant or award)
  19. 4 Open-market sale Chief Tech Ops Officer sold 2,000 shares at an average $128.84 ($257,676)
  20. 4 Grant or award Director acquired 1,846 shares (grant or award)

Page 6 of 34 · 672 filings